Answers are grounded in this paper and cite their sources.
Aim: Most of the previous studies with topical amphotericin B (AmB) have been done in chronic rhinosinusitis (CRS) patients with controversial results and studies targeting the discrete subgroup of allergic fungal rhinosinusitis (AFRS) are lacking. The purpose of the present study has been to evaluate and compare the efficacies of intranasal lavage by 200μg/mL AmB solution versus normal saline in AFRS patients after functional endoscopic sinus surgery (FESS). Materials and Methods: Sixty adult AFRS patients were divided postoperatively into two groups for intranasal lavage: group A with normal saline (control) and group B with 200μg/mL AmB solution (intervention). Symptom and nasal endoscopy scores were calculated and assessed in both the groups preoperatively, at 2 weeks, 1 month and 3 months follow-up along with recurrence post-surgery. Results: In group A, there were marked improvement in the mean symptom and nasal endoscopy scores at 2 weeks follow-up from the preoperative scores. Symptom scores deteriorated slightly at 1 and at 3 months followup while nasal endoscopy scores improved at 1 month and further at the end of 3 months. Similarly, group B showed significant improvement in the both the symptom and nasal endoscopy scores at 2 weeks. Mean symptom score deteriorated at 1 and 3 months follow-up while mean nasal endoscopy score improved at 1 month but deteriorated at 3 months follow-up. The intergroup differences were not significant. In group A, 46.66% patients had recurrence whereas in Group B, 70.0% had recurrence. Conclusion: We concluded that although there was a definite improvement in both the groups after 3 months, post-FESS intranasal lavage with 200µg/mL of AmB, a higher dose than conventionally used, did not confer a greater benefit as compared to normal saline irrigation. Clinical Significance: Efficacy of post operative topical AmB therapy, even in higher concentration, is no better than that with normal saline when studied exclusively in patients of AFRS.
No takes yet. Share an insight, caveat, or question.
Vaid et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: